CA9 anticorps (C-Term)

N° du produit ABIN540761

Détail du produit anti-CA9 anticorps

Antigène: CA9 (Carbonic Anhydrase IX (CA9))

Épitope: C-Term

Reactivité: Humain, Rat, Chien

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CA9 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunohistochemistry (Frozen Sections) (IHC (fro))

Fonction: Rabbit polyclonal antibody raised against synthetic peptide of CA9.

Specificité: This antibody is specific to human CA IX.

Réactivité croisée: Chien, Humain, Rat

Immunogène: A synthetic peptide corresponding to C-terminus of human CA9.

Information d'application

Indications d'application: Immunofluorescence (1:1000)
Immunohistochemistry (Frozen sections) (1:1000)
Western Blot (1:2000)
The optimal working dilution should be determined by the end user.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: In PBS (0.025 % sodium azide)

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C.
Aliquot to avoid repeated freezing and thawing.

Références pour anticorps anti-CA9 (ABIN540761)

Sathornsumetee, Cao, Marcello, Herndon, McLendon, Desjardins, Friedman, Dewhirst, Vredenburgh, Rich: "Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan." dans: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 26, Issue 2, pp. 271-8, (2008) (PubMed).

Sakata, Someya, Nagakura, Nakata, Oouchi, Takagi, Hareyama: "Brachytherapy for oral tongue cancer: an analysis of treatment results with various biological markers." dans: Japanese journal of clinical oncology, Vol. 38, Issue 6, pp. 402-7, (2008) (PubMed).

Yoo, Baia, Smith, McDermott, Bollen, Vandenberg, Lamborn, Lal: "Expression of the hypoxia marker carbonic anhydrase 9 is associated with anaplastic phenotypes in meningiomas." dans: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 13, Issue 1, pp. 68-75, (2007) (PubMed).

Westbury, Pearson, Nerurkar, Reis-Filho, Steele, Peckitt, Sharp, Yarnold: "Hypoxia can be detected in irradiated normal human tissue: a study using the hypoxic marker pimonidazole hydrochloride." dans: The British journal of radiology, Vol. 80, Issue 959, pp. 934-8, (2007) (PubMed).

Kaidi, Moorghen, Williams, Paraskeva: "Is the downregulation of EphB2 receptor expression during colorectal tumorigenesis due to hypoxia?" dans: Gut, Vol. 56, Issue 11, pp. 1637-8, (2007) (PubMed).

Détails sur CA9

Antigène: CA9 (Carbonic Anhydrase IX (CA9))

Autre désignation: Carbonic anhydrase 9 (CA9 Produits)

Synonymes: anticorps CA9, anticorps CAIX, anticorps Ca9, anticorps MN/CA9, anticorps MN, anticorps carbonic anhydrase 9, anticorps CA9, anticorps CAH9, anticorps Car9

ID gène: 768